Dyslipidemia, including high levels of total cholesterol, low-density lipoprotein cholesterol,
and triglyceride, and low levels of high-density lipoprotein cholesterol, is a major risk factor …

In Taiwan, the prevalence of hyperlipidemia increased due to lifestyle and dietary habit
changes. Low density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein …

Elevated circulating low-density lipoprotein cholesterol (LDL-C) is a major risk factor of
atherosclerotic cardiovascular disease (ASCVD). Early control of LDL-C to prevent ASCVD …

Background As mortality due to cardiovascular disease increases throughout the world,
accurate data on risk factors such as hyperlipidemia are required. This is lacking in the Asia …

Objective Understanding the determinants of low-density lipoprotein cholesterol (LDL-C)
control constitutes the basis of modelling interventions for optimal lipid control and …

Taiwanese heart registries for the main cardiovascular diseases have been conducted in the
past 10 years, with the goal of examining the quality of cardiovascular patient care, which …

Objective This study aimd to assess recent trends in the control of low-density lipoprotein
cholesterol (LDL-C) and the utilization of lipid-lowering drugs (LLD) among patients with …

Background Either classic or novel biomarkers have not been well investigated for clinical
outcomes of coronary artery disease (CAD) in Asian people especially ethnic Chinese. We …

Objective Whether a low-density lipoprotein cholesterol (LDL-C) goal is essential in
secondary prevention is still being debated. The aim of our study was to investigate whether …

Context: Statin is the main lipid-lowering therapy for type 2 diabetes mellitus patients.
Recent evidence suggested the cardiovascular protective effects of ezetimibe-simvastatin in …